You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-NKG2A

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis Trial in Shanghai, Kunming (Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection, Placebo)

Active, not recruiting
  • Psoriasis
  • Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
  • Placebo
  • Shanghai, Shanghai, China
  • +2 more
Nov 7, 2022

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Inhibition of Autophagy Synergizes Anti-tumor Effect Trial in Guangzhou (100mg bid dose of hydroxychloroquine combined with

Recruiting
  • Inhibition of Autophagy Synergizes Anti-tumor Effect
  • 100mg bid dose of hydroxychloroquine combined with three predefined dose groups of palbociclib
  • RP2D dose of 100mg bid of hydroxychloroquine combined with palbociclib was selected for phase II clinical trial.
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 19, 2023

Breast Cancer Trial in Guangzhou (Take probiotics)

Recruiting
  • Breast Cancer
  • Take probiotics
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 6, 2023

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

Recruiting
  • Melanoma (Skin)
  • +4 more
  • Bloomington, Minnesota
  • +7 more
Jan 31, 2023

Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer Trial (HST-1011, Cemiplimab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
Dec 14, 2022

HER2-low in Unresectable and/or Metastatic Breast Cancer

Not yet recruiting
  • Breast Neoplasms, Breast Cancer, Breast Carcinoma, Genes, HER-2, Genes, HER2
    • (no location specified)
    Nov 6, 2023

    Respiratory Syncytial Virus Infections Trial in Japan (Nirsevimab)

    Recruiting
    • Respiratory Syncytial Virus Infections
    • Bunkyo-ku, Japan
    • +11 more
    Sep 11, 2023

    Covid19 Trial in Nedlands (anti-SARS-CoV-2 IgY, Placebo)

    Completed
    • Covid19
    • anti-SARS-CoV-2 IgY
    • Placebo
    • Nedlands, Western Australia, Australia
      Linear Clinical Research - Harry Perkins Research Institute
    Jun 30, 2022

    anti_endometrial Antibodies in Endometriosis

    Active, not recruiting
    • Anti-endometrial Antibodies
    • serum anti-endometrial antibodies
    • Qena, Maabar, Egypt
      Mohammed Zain Al_a'bdeen
    May 1, 2023

    A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

    Recruiting
    • Immunocompromised Patients
    • Data collection
    • Paris, Ile De France, France
      Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
    Jul 5, 2022

    Advanced Solid Tumor Trial in Brussels (GTAEXS617)

    Recruiting
    • Advanced Solid Tumor
    • Brussels, Belgium
      Clinique Universitaires Saint-Luc
    Aug 8, 2023

    Hepatocellular Carcinoma, Glioblastoma, Medulloblastoma Trial in Jiujiang (NKG2D-based CAR T-cells)

    Withdrawn
    • Hepatocellular Carcinoma
    • +3 more
    • NKG2D-based CAR T-cells
    • Jiujiang, Jiangxi, China
      Affiliated hospital of jiujiang university
    Oct 18, 2020

    Idiopathic Inflammatory Myositis Trial (Daxdilimab, Placebo)

    Not yet recruiting
    • Idiopathic Inflammatory Myositis
    • (no location specified)
    Dec 20, 2022

    Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Aldesleukin
    • +12 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 9, 2023

    Solid Tumor, Peritoneal Metastases, Peritoneal Cancer Trial in Haifa, Jerusalem, Ramat Gan (Allocetra-OTS, nivolumab)

    Recruiting
    • Solid Tumor
    • +2 more
    • Haifa, Israel
    • +2 more
    Oct 12, 2022

    Real World Study on the Efficacy and Safety of Anti-HER2 Therapy

    Recruiting
    • Breast Neoplasms
    • HER2-positive Breast Cancer
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      May 5, 2022

      Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

      Recruiting
      • Adenocarcinoma
      • +8 more
      • Radiotherapy targeted to the primary lesion
      • +7 more
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 7, 2023

      Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Boston (Cessation of anti-HER2 treatment)

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • Cessation of anti-HER2 treatment
      • Boston, Massachusetts
      • +1 more
      Feb 9, 2023

      COVID-19 Trial in Milwaukee (anti-SARS-CoV-2 convalescent plasma)

      Completed
      • COVID-19
      • anti-SARS-CoV-2 convalescent plasma
      • Milwaukee, Wisconsin
        Froedtert Hospital
      Aug 23, 2022

      Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

      Recruiting
      • Solid Tumor, Adult
      • +19 more
      • Irving, Texas
      • +2 more
      May 24, 2023

      Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Portland, Suwon (AB-201, Cyclophosphamide,

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • Portland, Oregon
      • +1 more
      Jan 12, 2023

      NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • (no location specified)
      Sep 6, 2023

      Multiple Myeloma Trial in Orange, Sacramento, Oklahoma City (STI-1492)

      Recruiting
      • Multiple Myeloma
      • STI-1492
      • Orange, California
      • +2 more
      Jan 12, 2023